Literature DB >> 17878487

Celecoxib induces MRP-4 in lung cancer cells: therapeutic implications.

Angela Gradilone, Fabio Maria Pulcinelli, Lavinia Vittoria Lotti, Simone Martino, Teresa Mattiello, Luigi Frati, Anna Maria Aglianò, Paola Gazzaniga.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17878487     DOI: 10.1200/JCO.2007.12.2945

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  6 in total

1.  Induction of multidrug resistance proteins in lymphocytes from patients with arthritic disorders.

Authors:  Angela Gradilone; Antonio Spadaro; Walter Gianni; Anna Maria Aglianò; Paola Gazzaniga
Journal:  Clin Exp Med       Date:  2008-09-25       Impact factor: 3.984

Review 2.  Targeting the eicosanoid pathway in non-small-cell lung cancer.

Authors:  Leora Horn; Michael Backlund; David H Johnson
Journal:  Expert Opin Ther Targets       Date:  2009-05-02       Impact factor: 6.902

3.  COX-1 is coupled with mPGES-1 and ABCC4 in human cervix cancer cells.

Authors:  Hana Radilova; Antonin Libra; Sarka Holasova; Martina Safarova; Alena Viskova; Filip Kunc; Martin Buncek
Journal:  Mol Cell Biochem       Date:  2009-04-28       Impact factor: 3.396

4.  Celecoxib alleviates nonalcoholic fatty liver disease by restoring autophagic flux.

Authors:  Cong Liu; Lian Liu; Hai-Dan Zhu; Jia-Qi Sheng; Xiao-Li Wu; Xing-Xing He; De-An Tian; Jia-Zhi Liao; Pei-Yuan Li
Journal:  Sci Rep       Date:  2018-03-07       Impact factor: 4.379

5.  Identification of key genes and long non‑coding RNAs in celecoxib‑treated lung squamous cell carcinoma cell line by RNA‑sequencing.

Authors:  Gang Li; Xuehai Wang; Qingsong Luo; Chongzhi Gan
Journal:  Mol Med Rep       Date:  2018-03-01       Impact factor: 2.952

6.  MRP4 sustains Wnt/β-catenin signaling for pregnancy, endometriosis and endometrial cancer.

Authors:  Jun-Jiang Chen; Zhi-Jie Xiao; Xiaojing Meng; Yan Wang; Mei Kuen Yu; Wen Qing Huang; Xiao Sun; Hao Chen; Yong-Gang Duan; Xiaohua Jiang; Maria Pik Wong; Hsiao Chang Chan; Fei Zou; Ye Chun Ruan
Journal:  Theranostics       Date:  2019-07-09       Impact factor: 11.556

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.